Cours suspendu

Gouvernance LAVA Therapeutics

LVTX

NL0015000AG6

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 20/11/2025			Varia. 5j.	Varia. 1 janv.
1,740 ^USD	-3,87%		-.--%	-

21/11	Xoma Royalty finalise l'acquisition de Lava Therapeutics	MT
21/11	Xoma Royalty annonce la finalisation de l'acquisition de Lava Therapeutics N.V.	RE

Comité Exécutif: LAVA Therapeutics

Dirigeant

Fonctions occupéesDepuis

Amy Garabedian

General Counsel	27/07/2021
Corporate Secretary	27/07/2021

Jessica Truscello

Chief Tech/Sci/R&D Officer

09/11/2021

Wouter van Hunnik

Human Resources Officer

09/11/2021

Robin Hume

General Counsel

15/05/2023

Composition du Conseil d'Administration: LAVA Therapeutics

Administrateur

ComitésDepuis

Kapil Dhingra

66 ans

Compensation Committee	01/07/2017
Governance Committee Chair
Nominating Committee Chair

Karen Wilson

62 ans

Compensation Committee	01/04/2021
Audit Committee Chair	01/12/2025
Governance Committee	01/12/2025
Nominating Committee	01/12/2025
Compensation Committee Chair	15/01/2025

Owen Hughes

51 ans

Audit Committee	01/01/2024
Governance Committee	18/06/2025
Nominating Committee	18/06/2025

Maricel Montano

42 ans

Director/Board Member

07/11/2025

Bradley Sitko

45 ans

Director/Board Member

07/11/2025

Thomas Burns

51 ans

Director/Board Member

07/11/2025

Dernières Nominations: LAVA Therapeutics

09/03/23	LAVA Therapeutics N.V. annonce la nomination de Christy J. Oliger à son conseil d'administration	CI
06/02/23	LAVA Therapeutics N.V. annonce la nomination du Dr Charles Morris au poste de médecin en chef	CI
06/01/23	LAVA Therapeutics N.V. annonce des changements au sein de son conseil d'administration	CI
01/11/22	Lava Therapeutics nomme Fred Powell directeur financier	MT
15/06/22	LAVA Therapeutics N.V. annonce des changements au sein de son conseil d'administration	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: LAVA Therapeutics

Insider

Fonctions occupées

DepuisJusqu'au

Fred Powell

Director of Finance/CFO

01/11/2022

21/11/2025

Stephen Hurly

Director/Board Member	01/06/2019	07/11/2025
Chief Executive Officer	01/06/2019	21/11/2025
President	01/06/2019	21/11/2025

Christy Oliger

Director/Board Member	09/03/2023	07/11/2025
Independent Dir/Board Member	09/03/2023	07/11/2025

James Noble

Director/Board Member	15/06/2022	07/11/2025
Independent Dir/Board Member	15/06/2022	07/11/2025

Peter Kiener

Director/Board Member	01/01/2023	07/11/2025
Independent Dir/Board Member	01/01/2023	07/11/2025

Jay Backstrom

Director/Board Member	15/06/2022	07/11/2025
Independent Dir/Board Member	15/06/2022	07/11/2025

Mary Wadlinger

Director/Board Member	01/01/2023	07/11/2025
Independent Dir/Board Member	01/01/2023	07/11/2025

Charles Morris

Chief Tech/Sci/R&D Officer

06/02/2023

01/10/2025

Oxana Polyakova

Chief Tech/Sci/R&D Officer

01/07/2021

01/01/2025

Michael McNamara

Corporate Officer/Principal

01/06/2021

01/07/2023

Stefan Luzi

Director/Board Member

01/01/2018

09/03/2023

Benjamin Winograd

Chief Tech/Sci/R&D Officer

01/07/2020

06/02/2023

Guido Magni

Director/Board Member

01/05/2018

01/01/2023

Erik van den Berg

Director/Board Member	01/02/2021	15/06/2022
Chairman	01/03/2018	01/02/2021
Founder	01/01/2016	15/06/2022
Independent Dir/Board Member	01/01/2016	15/06/2022

Joël Jean-Mairet

Director/Board Member

01/01/2019

15/06/2022

Nanna Liebach Lüneborg

Director/Board Member

01/09/2020

15/06/2022

Edward Smith

Director of Finance/CFO

15/03/2021

17/05/2022

Sumeet Ambarkhane

Chief Tech/Sci/R&D Officer

09/11/2021

01/01/2022

Stephen DiPalma

Director of Finance/CFO

15/03/2021

Paul W. H. I. Parren

Chief Tech/Sci/R&D Officer

01/05/2018

Laia Crespo Martin

Director/Board Member

Reza Halse

Director/Board Member

Jan C. M. van der Hoeven

Director/Board Member

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	9
Femme	4

Dont comité exécutif

Homme	2
Femme	2

Dont Administrateurs

Homme	4
Femme	2

LAVA Therapeutics NV, anciennement Lava Therapeutics BV, est un prestataire de services de recherche et développement en biotechnologie basé aux Pays-Bas. La société se consacre au développement d'anticorps bispécifiques de nouvelle génération ciblant les lymphocytes T V-delta pour lutter contre le cancer.

Employés

Secteur

Recherche biotechnologique et médicale

Plus d'informations sur la société